Pharma and Health Care Industry Research Report 2023
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
Highlights
The global Pharma and Health Care market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharma and Health Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma and Health Care.
The Pharma and Health Care market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharma and Health Care market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma and Health Care companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Pharma and Health Care type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Pharma and Health Care are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Pharma and Health Care segment by Format
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pharma and Health Care market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pharma and Health Care market.
Pharma and Health Care Segment by Prescription
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pharma and Health Care market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pharma and Health Care industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharma and Health Care companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
Highlights
The global Pharma and Health Care market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharma and Health Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma and Health Care.
The Pharma and Health Care market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharma and Health Care market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma and Health Care companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Johnson & Johnson
- Novartis
- Roche
- AbbVie
- Merck & Co.
- Bristol Myers Squibb
- GlaxoSmithKline
- Pfizer
- Sanofi
- Takeda
- AstraZeneca
- Bayer
- Eli Lilly & Co.
- Gilead Sciences
- Amgen
- Novo Nordisk
- Teva
- Boehringer Ingelheim
- Biogen
- Astellas
Global markets are presented by Pharma and Health Care type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Pharma and Health Care are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Pharma and Health Care segment by Format
- Bottle
- Blister
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pharma and Health Care market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pharma and Health Care market.
Pharma and Health Care Segment by Prescription
- OTC Drugs
- Prescription Drugs
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pharma and Health Care market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pharma and Health Care industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharma and Health Care companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Pharma and Health Care by Format
2.2.1 Market Value Comparison by Format (2018 VS 2022 VS 2029)
1.2.2 Bottle
1.2.3 Blister
1.2.4 Others
2.3 Pharma and Health Care by Prescription
2.3.1 Market Value Comparison by Prescription (2018 VS 2022 VS 2029)
2.3.2 OTC Drugs
2.3.3 Prescription Drugs
2.4 Assumptions and Limitations
3 PHARMA AND HEALTH CARE BREAKDOWN DATA BY FORMAT
3.1 Global Pharma and Health Care Historic Market Size by Format (2018-2023)
3.2 Global Pharma and Health Care Forecasted Market Size by Format (2023-2028)
4 PHARMA AND HEALTH CARE BREAKDOWN DATA BY PRESCRIPTION
4.1 Global Pharma and Health Care Historic Market Size by Prescription (2018-2023)
4.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Pharma and Health Care Market Perspective (2018-2029)
5.2 Global Pharma and Health Care Growth Trends by Region
5.2.1 Global Pharma and Health Care Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Pharma and Health Care Historic Market Size by Region (2018-2023)
5.2.3 Pharma and Health Care Forecasted Market Size by Region (2024-2029)
5.3 Pharma and Health Care Market Dynamics
5.3.1 Pharma and Health Care Industry Trends
5.3.2 Pharma and Health Care Market Drivers
5.3.3 Pharma and Health Care Market Challenges
5.3.4 Pharma and Health Care Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Pharma and Health Care Players by Revenue
6.1.1 Global Top Pharma and Health Care Players by Revenue (2018-2023)
6.1.2 Global Pharma and Health Care Revenue Market Share by Players (2018-2023)
6.2 Global Pharma and Health Care Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Pharma and Health Care Head office and Area Served
6.4 Global Pharma and Health Care Players, Product Type & Application
6.5 Global Pharma and Health Care Players, Date of Enter into This Industry
6.6 Global Pharma and Health Care Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Pharma and Health Care Market Size (2018-2029)
7.2 North America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Pharma and Health Care Market Size by Country (2018-2023)
7.4 North America Pharma and Health Care Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Pharma and Health Care Market Size (2018-2029)
8.2 Europe Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Pharma and Health Care Market Size by Country (2018-2023)
8.4 Europe Pharma and Health Care Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Pharma and Health Care Market Size (2018-2029)
9.2 Asia-Pacific Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Pharma and Health Care Market Size by Country (2018-2023)
9.4 Asia-Pacific Pharma and Health Care Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Pharma and Health Care Market Size (2018-2029)
10.2 Latin America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Pharma and Health Care Market Size by Country (2018-2023)
10.4 Latin America Pharma and Health Care Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pharma and Health Care Market Size (2018-2029)
11.2 Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Pharma and Health Care Market Size by Country (2018-2023)
11.4 Middle East & Africa Pharma and Health Care Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Pharma and Health Care Introduction
11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2017-2022)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pharma and Health Care Introduction
11.2.4 Novartis Revenue in Pharma and Health Care Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Pharma and Health Care Introduction
11.3.4 Roche Revenue in Pharma and Health Care Business (2017-2022)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Pharma and Health Care Introduction
11.4.4 AbbVie Revenue in Pharma and Health Care Business (2017-2022)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Pharma and Health Care Introduction
11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2017-2022)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction
11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2017-2022)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pharma and Health Care Introduction
11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2017-2022)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pharma and Health Care Introduction
11.8.4 Pfizer Revenue in Pharma and Health Care Business (2017-2022)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Pharma and Health Care Introduction
11.9.4 Sanofi Revenue in Pharma and Health Care Business (2017-2022)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Pharma and Health Care Introduction
11.10.4 Takeda Revenue in Pharma and Health Care Business (2017-2022)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Pharma and Health Care Introduction
11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2017-2022)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Pharma and Health Care Introduction
11.12.4 Bayer Revenue in Pharma and Health Care Business (2017-2022)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Detail
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction
11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2017-2022)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Pharma and Health Care Introduction
11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2017-2022)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Pharma and Health Care Introduction
11.15.4 Amgen Revenue in Pharma and Health Care Business (2017-2022)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Pharma and Health Care Introduction
11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2017-2022)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Detail
11.17.2 Teva Business Overview
11.17.3 Teva Pharma and Health Care Introduction
11.17.4 Teva Revenue in Pharma and Health Care Business (2017-2022)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Detail
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction
11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2017-2022)
11.18.5 Boehringer Ingelheim Recent Development
11.19 Biogen
11.19.1 Biogen Company Detail
11.19.2 Biogen Business Overview
11.19.3 Biogen Pharma and Health Care Introduction
11.19.4 Biogen Revenue in Pharma and Health Care Business (2017-2022)
11.19.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Detail
11.20.2 Astellas Business Overview
11.20.3 Astellas Pharma and Health Care Introduction
11.20.4 Astellas Revenue in Pharma and Health Care Business (2017-2022)
11.20.5 Astellas Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Pharma and Health Care by Format
2.2.1 Market Value Comparison by Format (2018 VS 2022 VS 2029)
1.2.2 Bottle
1.2.3 Blister
1.2.4 Others
2.3 Pharma and Health Care by Prescription
2.3.1 Market Value Comparison by Prescription (2018 VS 2022 VS 2029)
2.3.2 OTC Drugs
2.3.3 Prescription Drugs
2.4 Assumptions and Limitations
3 PHARMA AND HEALTH CARE BREAKDOWN DATA BY FORMAT
3.1 Global Pharma and Health Care Historic Market Size by Format (2018-2023)
3.2 Global Pharma and Health Care Forecasted Market Size by Format (2023-2028)
4 PHARMA AND HEALTH CARE BREAKDOWN DATA BY PRESCRIPTION
4.1 Global Pharma and Health Care Historic Market Size by Prescription (2018-2023)
4.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Pharma and Health Care Market Perspective (2018-2029)
5.2 Global Pharma and Health Care Growth Trends by Region
5.2.1 Global Pharma and Health Care Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Pharma and Health Care Historic Market Size by Region (2018-2023)
5.2.3 Pharma and Health Care Forecasted Market Size by Region (2024-2029)
5.3 Pharma and Health Care Market Dynamics
5.3.1 Pharma and Health Care Industry Trends
5.3.2 Pharma and Health Care Market Drivers
5.3.3 Pharma and Health Care Market Challenges
5.3.4 Pharma and Health Care Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Pharma and Health Care Players by Revenue
6.1.1 Global Top Pharma and Health Care Players by Revenue (2018-2023)
6.1.2 Global Pharma and Health Care Revenue Market Share by Players (2018-2023)
6.2 Global Pharma and Health Care Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Pharma and Health Care Head office and Area Served
6.4 Global Pharma and Health Care Players, Product Type & Application
6.5 Global Pharma and Health Care Players, Date of Enter into This Industry
6.6 Global Pharma and Health Care Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Pharma and Health Care Market Size (2018-2029)
7.2 North America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Pharma and Health Care Market Size by Country (2018-2023)
7.4 North America Pharma and Health Care Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Pharma and Health Care Market Size (2018-2029)
8.2 Europe Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Pharma and Health Care Market Size by Country (2018-2023)
8.4 Europe Pharma and Health Care Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Pharma and Health Care Market Size (2018-2029)
9.2 Asia-Pacific Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Pharma and Health Care Market Size by Country (2018-2023)
9.4 Asia-Pacific Pharma and Health Care Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Pharma and Health Care Market Size (2018-2029)
10.2 Latin America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Pharma and Health Care Market Size by Country (2018-2023)
10.4 Latin America Pharma and Health Care Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pharma and Health Care Market Size (2018-2029)
11.2 Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Pharma and Health Care Market Size by Country (2018-2023)
11.4 Middle East & Africa Pharma and Health Care Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Pharma and Health Care Introduction
11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2017-2022)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pharma and Health Care Introduction
11.2.4 Novartis Revenue in Pharma and Health Care Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Pharma and Health Care Introduction
11.3.4 Roche Revenue in Pharma and Health Care Business (2017-2022)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Pharma and Health Care Introduction
11.4.4 AbbVie Revenue in Pharma and Health Care Business (2017-2022)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Pharma and Health Care Introduction
11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2017-2022)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction
11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2017-2022)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pharma and Health Care Introduction
11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2017-2022)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pharma and Health Care Introduction
11.8.4 Pfizer Revenue in Pharma and Health Care Business (2017-2022)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Pharma and Health Care Introduction
11.9.4 Sanofi Revenue in Pharma and Health Care Business (2017-2022)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Pharma and Health Care Introduction
11.10.4 Takeda Revenue in Pharma and Health Care Business (2017-2022)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Pharma and Health Care Introduction
11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2017-2022)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Pharma and Health Care Introduction
11.12.4 Bayer Revenue in Pharma and Health Care Business (2017-2022)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Detail
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction
11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2017-2022)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Pharma and Health Care Introduction
11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2017-2022)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Pharma and Health Care Introduction
11.15.4 Amgen Revenue in Pharma and Health Care Business (2017-2022)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Pharma and Health Care Introduction
11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2017-2022)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Detail
11.17.2 Teva Business Overview
11.17.3 Teva Pharma and Health Care Introduction
11.17.4 Teva Revenue in Pharma and Health Care Business (2017-2022)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Detail
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction
11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2017-2022)
11.18.5 Boehringer Ingelheim Recent Development
11.19 Biogen
11.19.1 Biogen Company Detail
11.19.2 Biogen Business Overview
11.19.3 Biogen Pharma and Health Care Introduction
11.19.4 Biogen Revenue in Pharma and Health Care Business (2017-2022)
11.19.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Detail
11.20.2 Astellas Business Overview
11.20.3 Astellas Pharma and Health Care Introduction
11.20.4 Astellas Revenue in Pharma and Health Care Business (2017-2022)
11.20.5 Astellas Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Format (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Prescription (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pharma and Health Care Market Size by Format (2018-2023) & (US$ Million)
Table 6. Global Pharma and Health Care Revenue Market Share by Format (2018-2023)
Table 7. Global Pharma and Health Care Forecasted Market Size by Format (2024-2029) & (US$ Million)
Table 8. Global Pharma and Health Care Revenue Market Share by Format (2024-2029)
Table 9. Global Pharma and Health Care Market Size by Prescription (2018-2023) & (US$ Million)
Table 10. Global Pharma and Health Care Revenue Market Share by Prescription (2018-2023)
Table 11. Global Pharma and Health Care Forecasted Market Size by Prescription (2024-2029) & (US$ Million)
Table 12. Global Pharma and Health Care Revenue Market Share by Prescription (2024-2029)
Table 13. Global Pharma and Health Care Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Pharma and Health Care Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Pharma and Health Care Market Share by Region (2018-2023)
Table 16. Global Pharma and Health Care Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Pharma and Health Care Market Share by Region (2024-2029)
Table 18. Pharma and Health Care Market Trends
Table 19. Pharma and Health Care Market Drivers
Table 20. Pharma and Health Care Market Challenges
Table 21. Pharma and Health Care Market Restraints
Table 22. Global Top Pharma and Health Care Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Pharma and Health Care Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Pharma and Health Care Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Pharma and Health Care, Headquarters and Area Served
Table 26. Global Pharma and Health Care Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pharma and Health Care by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 45. Johnson & Johnson Company Detail
Table 46. Johnson & Johnson Business Overview
Table 47. Johnson & Johnson Pharma and Health Care Product
Table 48. Johnson & Johnson Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 49. Johnson & Johnson Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Pharma and Health Care Product
Table 53. Novartis Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Roche Company Detail
Table 56. Roche Business Overview
Table 57. Roche Pharma and Health Care Product
Table 58. Roche Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 59. Roche Recent Development
Table 60. AbbVie Company Detail
Table 61. AbbVie Business Overview
Table 62. AbbVie Pharma and Health Care Product
Table 63. AbbVie Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 64. AbbVie Recent Development
Table 65. Merck & Co. Company Detail
Table 66. Merck & Co. Business Overview
Table 67. Merck & Co. Pharma and Health Care Product
Table 68. Merck & Co. Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 69. Merck & Co. Recent Development
Table 70. Bristol Myers Squibb Company Detail
Table 71. Bristol Myers Squibb Business Overview
Table 72. Bristol Myers Squibb Pharma and Health Care Product
Table 73. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 74. Bristol Myers Squibb Recent Development
Table 75. GlaxoSmithKline Company Detail
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Pharma and Health Care Product
Table 78. GlaxoSmithKline Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 79. GlaxoSmithKline Recent Development
Table 80. Pfizer Company Detail
Table 81. Pfizer Business Overview
Table 82. Pfizer Pharma and Health Care Product
Table 83. Pfizer Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Pharma and Health Care Product
Table 88. Sanofi Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Takeda Company Detail
Table 91. Takeda Business Overview
Table 92. Takeda Pharma and Health Care Product
Table 93. Takeda Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 94. Takeda Recent Development
Table 95. AstraZeneca Company Detail
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Pharma and Health CareProduct
Table 98. AstraZeneca Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Bayer Company Detail
Table 101. Bayer Business Overview
Table 102. Bayer Pharma and Health CareProduct
Table 103. Bayer Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 104. Bayer Recent Development
Table 105. Eli Lilly & Co. Company Detail
Table 106. Eli Lilly & Co. Business Overview
Table 107. Eli Lilly & Co. Pharma and Health CareProduct
Table 108. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 109. Eli Lilly & Co. Recent Development
Table 110. Gilead Sciences Company Detail
Table 111. Gilead Sciences Business Overview
Table 112. Gilead Sciences Pharma and Health CareProduct
Table 113. Gilead Sciences Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 114. Gilead Sciences Recent Development
Table 115. Amgen Company Detail
Table 116. Amgen Business Overview
Table 117. Amgen Pharma and Health CareProduct
Table 118. Amgen Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 119. Amgen Recent Development
Table 120. Novo Nordisk Company Detail
Table 121. Novo Nordisk Business Overview
Table 122. Novo Nordisk Pharma and Health CareProduct
Table 123. Novo Nordisk Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 124. Novo Nordisk Recent Development
Table 125. Teva Company Detail
Table 126. Teva Business Overview
Table 127. Teva Pharma and Health CareProduct
Table 128. Teva Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 129. Teva Recent Development
Table 130. Boehringer Ingelheim Company Detail
Table 131. Boehringer Ingelheim Business Overview
Table 132. Boehringer Ingelheim Pharma and Health CareProduct
Table 133. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 134. Boehringer Ingelheim Recent Development
Table 135. Biogen Company Detail
Table 136. Biogen Business Overview
Table 137. Biogen Pharma and Health CareProduct
Table 138. Biogen Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 139. Biogen Recent Development
Table 140. Astellas Company Detail
Table 141. Astellas Business Overview
Table 142. Astellas Pharma and Health CareProduct
Table 143. Astellas Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 144. Astellas Recent Development
Table 145. Johnson & Johnson Company Information
Table 146. Johnson & Johnson Business Overview
Table 147. Johnson & Johnson Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 148. Johnson & Johnson Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 149. Johnson & Johnson Recent Development
Table 150. Novartis Company Information
Table 151. Novartis Business Overview
Table 152. Novartis Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 153. Novartis Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 154. Novartis Recent Development
Table 155. Roche Company Information
Table 156. Roche Business Overview
Table 157. Roche Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 158. Roche Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 159. Roche Recent Development
Table 160. AbbVie Company Information
Table 161. AbbVie Business Overview
Table 162. AbbVie Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 163. AbbVie Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 164. AbbVie Recent Development
Table 165. Merck & Co. Company Information
Table 166. Merck & Co. Business Overview
Table 167. Merck & Co. Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 168. Merck & Co. Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 169. Merck & Co. Recent Development
Table 170. Bristol Myers Squibb Company Information
Table 171. Bristol Myers Squibb Business Overview
Table 172. Bristol Myers Squibb Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 173. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 174. Bristol Myers Squibb Recent Development
Table 175. GlaxoSmithKline Company Information
Table 176. GlaxoSmithKline Business Overview
Table 177. GlaxoSmithKline Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 178. GlaxoSmithKline Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 179. GlaxoSmithKline Recent Development
Table 180. Pfizer Company Information
Table 181. Pfizer Business Overview
Table 182. Pfizer Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 183. Pfizer Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 184. Pfizer Recent Development
Table 185. Sanofi Company Information
Table 186. Sanofi Business Overview
Table 187. Sanofi Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 188. Sanofi Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 189. Sanofi Recent Development
Table 190. Takeda Company Information
Table 191. Takeda Business Overview
Table 192. Takeda Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 193. Takeda Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 194. Takeda Recent Development
Table 195. AstraZeneca Company Information
Table 196. AstraZeneca Business Overview
Table 197. AstraZeneca Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 198. AstraZeneca Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 199. AstraZeneca Recent Development
Table 200. Bayer Company Information
Table 201. Bayer Business Overview
Table 202. Bayer Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 203. Bayer Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 204. Bayer Recent Development
Table 205. Eli Lilly & Co. Company Information
Table 206. Eli Lilly & Co. Business Overview
Table 207. Eli Lilly & Co. Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 208. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 209. Eli Lilly & Co. Recent Development
Table 210. Gilead Sciences Company Information
Table 211. Gilead Sciences Business Overview
Table 212. Gilead Sciences Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 213. Gilead Sciences Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 214. Gilead Sciences Recent Development
Table 215. Amgen Company Information
Table 216. Amgen Business Overview
Table 217. Amgen Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 218. Amgen Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 219. Amgen Recent Development
Table 220. Novo Nordisk Company Information
Table 221. Novo Nordisk Business Overview
Table 222. Novo Nordisk Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 223. Novo Nordisk Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 224. Novo Nordisk Recent Development
Table 225. Teva Company Information
Table 226. Teva Business Overview
Table 227. Teva Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 228. Teva Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 229. Teva Recent Development
Table 230. Boehringer Ingelheim Company Information
Table 231. Boehringer Ingelheim Business Overview
Table 232. Boehringer Ingelheim Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 233. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 234. Boehringer Ingelheim Recent Development
Table 235. Biogen Company Information
Table 236. Biogen Business Overview
Table 237. Biogen Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 238. Biogen Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 239. Biogen Recent Development
Table 240. Astellas Company Information
Table 241. Astellas Business Overview
Table 242. Astellas Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 243. Astellas Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 244. Astellas Recent Development
Table 245. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Format (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Prescription (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pharma and Health Care Market Size by Format (2018-2023) & (US$ Million)
Table 6. Global Pharma and Health Care Revenue Market Share by Format (2018-2023)
Table 7. Global Pharma and Health Care Forecasted Market Size by Format (2024-2029) & (US$ Million)
Table 8. Global Pharma and Health Care Revenue Market Share by Format (2024-2029)
Table 9. Global Pharma and Health Care Market Size by Prescription (2018-2023) & (US$ Million)
Table 10. Global Pharma and Health Care Revenue Market Share by Prescription (2018-2023)
Table 11. Global Pharma and Health Care Forecasted Market Size by Prescription (2024-2029) & (US$ Million)
Table 12. Global Pharma and Health Care Revenue Market Share by Prescription (2024-2029)
Table 13. Global Pharma and Health Care Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Pharma and Health Care Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Pharma and Health Care Market Share by Region (2018-2023)
Table 16. Global Pharma and Health Care Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Pharma and Health Care Market Share by Region (2024-2029)
Table 18. Pharma and Health Care Market Trends
Table 19. Pharma and Health Care Market Drivers
Table 20. Pharma and Health Care Market Challenges
Table 21. Pharma and Health Care Market Restraints
Table 22. Global Top Pharma and Health Care Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Pharma and Health Care Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Pharma and Health Care Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Pharma and Health Care, Headquarters and Area Served
Table 26. Global Pharma and Health Care Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pharma and Health Care by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Pharma and Health Care Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Pharma and Health Care Market Size by Country (2024-2029) & (US$ Million)
Table 45. Johnson & Johnson Company Detail
Table 46. Johnson & Johnson Business Overview
Table 47. Johnson & Johnson Pharma and Health Care Product
Table 48. Johnson & Johnson Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 49. Johnson & Johnson Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Pharma and Health Care Product
Table 53. Novartis Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Roche Company Detail
Table 56. Roche Business Overview
Table 57. Roche Pharma and Health Care Product
Table 58. Roche Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 59. Roche Recent Development
Table 60. AbbVie Company Detail
Table 61. AbbVie Business Overview
Table 62. AbbVie Pharma and Health Care Product
Table 63. AbbVie Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 64. AbbVie Recent Development
Table 65. Merck & Co. Company Detail
Table 66. Merck & Co. Business Overview
Table 67. Merck & Co. Pharma and Health Care Product
Table 68. Merck & Co. Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 69. Merck & Co. Recent Development
Table 70. Bristol Myers Squibb Company Detail
Table 71. Bristol Myers Squibb Business Overview
Table 72. Bristol Myers Squibb Pharma and Health Care Product
Table 73. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 74. Bristol Myers Squibb Recent Development
Table 75. GlaxoSmithKline Company Detail
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Pharma and Health Care Product
Table 78. GlaxoSmithKline Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 79. GlaxoSmithKline Recent Development
Table 80. Pfizer Company Detail
Table 81. Pfizer Business Overview
Table 82. Pfizer Pharma and Health Care Product
Table 83. Pfizer Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Pharma and Health Care Product
Table 88. Sanofi Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Takeda Company Detail
Table 91. Takeda Business Overview
Table 92. Takeda Pharma and Health Care Product
Table 93. Takeda Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 94. Takeda Recent Development
Table 95. AstraZeneca Company Detail
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Pharma and Health CareProduct
Table 98. AstraZeneca Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Bayer Company Detail
Table 101. Bayer Business Overview
Table 102. Bayer Pharma and Health CareProduct
Table 103. Bayer Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 104. Bayer Recent Development
Table 105. Eli Lilly & Co. Company Detail
Table 106. Eli Lilly & Co. Business Overview
Table 107. Eli Lilly & Co. Pharma and Health CareProduct
Table 108. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 109. Eli Lilly & Co. Recent Development
Table 110. Gilead Sciences Company Detail
Table 111. Gilead Sciences Business Overview
Table 112. Gilead Sciences Pharma and Health CareProduct
Table 113. Gilead Sciences Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 114. Gilead Sciences Recent Development
Table 115. Amgen Company Detail
Table 116. Amgen Business Overview
Table 117. Amgen Pharma and Health CareProduct
Table 118. Amgen Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 119. Amgen Recent Development
Table 120. Novo Nordisk Company Detail
Table 121. Novo Nordisk Business Overview
Table 122. Novo Nordisk Pharma and Health CareProduct
Table 123. Novo Nordisk Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 124. Novo Nordisk Recent Development
Table 125. Teva Company Detail
Table 126. Teva Business Overview
Table 127. Teva Pharma and Health CareProduct
Table 128. Teva Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 129. Teva Recent Development
Table 130. Boehringer Ingelheim Company Detail
Table 131. Boehringer Ingelheim Business Overview
Table 132. Boehringer Ingelheim Pharma and Health CareProduct
Table 133. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 134. Boehringer Ingelheim Recent Development
Table 135. Biogen Company Detail
Table 136. Biogen Business Overview
Table 137. Biogen Pharma and Health CareProduct
Table 138. Biogen Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 139. Biogen Recent Development
Table 140. Astellas Company Detail
Table 141. Astellas Business Overview
Table 142. Astellas Pharma and Health CareProduct
Table 143. Astellas Revenue in Pharma and Health Care Business (2017-2022) & (US$ Million)
Table 144. Astellas Recent Development
Table 145. Johnson & Johnson Company Information
Table 146. Johnson & Johnson Business Overview
Table 147. Johnson & Johnson Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 148. Johnson & Johnson Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 149. Johnson & Johnson Recent Development
Table 150. Novartis Company Information
Table 151. Novartis Business Overview
Table 152. Novartis Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 153. Novartis Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 154. Novartis Recent Development
Table 155. Roche Company Information
Table 156. Roche Business Overview
Table 157. Roche Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 158. Roche Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 159. Roche Recent Development
Table 160. AbbVie Company Information
Table 161. AbbVie Business Overview
Table 162. AbbVie Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 163. AbbVie Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 164. AbbVie Recent Development
Table 165. Merck & Co. Company Information
Table 166. Merck & Co. Business Overview
Table 167. Merck & Co. Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 168. Merck & Co. Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 169. Merck & Co. Recent Development
Table 170. Bristol Myers Squibb Company Information
Table 171. Bristol Myers Squibb Business Overview
Table 172. Bristol Myers Squibb Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 173. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 174. Bristol Myers Squibb Recent Development
Table 175. GlaxoSmithKline Company Information
Table 176. GlaxoSmithKline Business Overview
Table 177. GlaxoSmithKline Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 178. GlaxoSmithKline Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 179. GlaxoSmithKline Recent Development
Table 180. Pfizer Company Information
Table 181. Pfizer Business Overview
Table 182. Pfizer Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 183. Pfizer Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 184. Pfizer Recent Development
Table 185. Sanofi Company Information
Table 186. Sanofi Business Overview
Table 187. Sanofi Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 188. Sanofi Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 189. Sanofi Recent Development
Table 190. Takeda Company Information
Table 191. Takeda Business Overview
Table 192. Takeda Pharma and Health Care Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 193. Takeda Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 194. Takeda Recent Development
Table 195. AstraZeneca Company Information
Table 196. AstraZeneca Business Overview
Table 197. AstraZeneca Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 198. AstraZeneca Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 199. AstraZeneca Recent Development
Table 200. Bayer Company Information
Table 201. Bayer Business Overview
Table 202. Bayer Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 203. Bayer Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 204. Bayer Recent Development
Table 205. Eli Lilly & Co. Company Information
Table 206. Eli Lilly & Co. Business Overview
Table 207. Eli Lilly & Co. Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 208. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 209. Eli Lilly & Co. Recent Development
Table 210. Gilead Sciences Company Information
Table 211. Gilead Sciences Business Overview
Table 212. Gilead Sciences Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 213. Gilead Sciences Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 214. Gilead Sciences Recent Development
Table 215. Amgen Company Information
Table 216. Amgen Business Overview
Table 217. Amgen Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 218. Amgen Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 219. Amgen Recent Development
Table 220. Novo Nordisk Company Information
Table 221. Novo Nordisk Business Overview
Table 222. Novo Nordisk Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 223. Novo Nordisk Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 224. Novo Nordisk Recent Development
Table 225. Teva Company Information
Table 226. Teva Business Overview
Table 227. Teva Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 228. Teva Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 229. Teva Recent Development
Table 230. Boehringer Ingelheim Company Information
Table 231. Boehringer Ingelheim Business Overview
Table 232. Boehringer Ingelheim Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 233. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 234. Boehringer Ingelheim Recent Development
Table 235. Biogen Company Information
Table 236. Biogen Business Overview
Table 237. Biogen Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 238. Biogen Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 239. Biogen Recent Development
Table 240. Astellas Company Information
Table 241. Astellas Business Overview
Table 242. Astellas Pharma and Health CareRevenue in Pharma and Health Care Business (2018-2023) & (US$ Million)
Table 243. Astellas Revenue in Pharma and Health Care Business (2018-2023) & (US$ Million) Portfolio
Table 244. Astellas Recent Development
Table 245. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pharma and Health Care Product Picture
Figure 5. Global Pharma and Health Care Market Size Comparison by Format (2023-2029) & (US$ Million)
Figure 6. Global Pharma and Health Care Market Share by Format: 2022 VS 2029
Figure 7. Bottle Product Picture
Figure 8. Blister Product Picture
Figure 9. Others Product Picture
Figure 10. Global Pharma and Health Care Market Size by Prescription (2023-2029) & (US$ Million)
Figure 11. Global Pharma and Health Care Market Share by Prescription: 2022 VS 2029
Figure 12. OTC Drugs Product Picture
Figure 13. Prescription Drugs Product Picture
Figure 14. Global Pharma and Health Care Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Pharma and Health Care Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Pharma and Health Care Market Share by Region: 2022 VS 2029
Figure 17. Global Pharma and Health Care Market Share by Players in 2022
Figure 18. Global Pharma and Health Care Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Pharma and Health Care Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Pharma and Health Care Market Share by Country (2018-2029)
Figure 23. United States Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Pharma and Health Care Market Share by Country (2018-2029)
Figure 27. Germany Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Pharma and Health Care Market Share by Country (2018-2029)
Figure 35. China Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Pharma and Health Care Market Share by Country (2018-2029)
Figure 43. Mexico Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Pharma and Health Care Market Share by Country (2018-2029)
Figure 47. Turkey Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Johnson & Johnson Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 53. AbbVie Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 54. Merck & Co. Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 55. Bristol Myers Squibb Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 58. Sanofi Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 59. Takeda Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 60. AstraZeneca Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 61. Bayer Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 62. Eli Lilly & Co. Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 63. Gilead Sciences Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 64. Amgen Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 65. Novo Nordisk Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 66. Teva Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 68. Biogen Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 69. Astellas Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pharma and Health Care Product Picture
Figure 5. Global Pharma and Health Care Market Size Comparison by Format (2023-2029) & (US$ Million)
Figure 6. Global Pharma and Health Care Market Share by Format: 2022 VS 2029
Figure 7. Bottle Product Picture
Figure 8. Blister Product Picture
Figure 9. Others Product Picture
Figure 10. Global Pharma and Health Care Market Size by Prescription (2023-2029) & (US$ Million)
Figure 11. Global Pharma and Health Care Market Share by Prescription: 2022 VS 2029
Figure 12. OTC Drugs Product Picture
Figure 13. Prescription Drugs Product Picture
Figure 14. Global Pharma and Health Care Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Pharma and Health Care Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Pharma and Health Care Market Share by Region: 2022 VS 2029
Figure 17. Global Pharma and Health Care Market Share by Players in 2022
Figure 18. Global Pharma and Health Care Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Pharma and Health Care Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Pharma and Health Care Market Share by Country (2018-2029)
Figure 23. United States Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Pharma and Health Care Market Share by Country (2018-2029)
Figure 27. Germany Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Pharma and Health Care Market Share by Country (2018-2029)
Figure 35. China Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Pharma and Health Care Market Share by Country (2018-2029)
Figure 43. Mexico Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Pharma and Health Care Market Share by Country (2018-2029)
Figure 47. Turkey Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Pharma and Health Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Johnson & Johnson Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 53. AbbVie Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 54. Merck & Co. Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 55. Bristol Myers Squibb Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 58. Sanofi Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 59. Takeda Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 60. AstraZeneca Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 61. Bayer Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 62. Eli Lilly & Co. Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 63. Gilead Sciences Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 64. Amgen Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 65. Novo Nordisk Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 66. Teva Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 68. Biogen Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
Figure 69. Astellas Revenue Growth Rate in Pharma and Health Care Business (2018-2023)
